Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Cinclus Pharma Holding Ab

Clinical trials sponsored by Cinclus Pharma Holding Ab, explained in plain language.

Not yet recruiting 2 Completed 1
Sort by
  • New GERD drug aims to keep esophagus healed longer

    Disease control Not yet recruiting

    This phase 3 trial tests whether a new drug, linaprazan glurate, can keep the esophagus healed in people with healed erosive esophagitis from GERD, compared to the standard drug lansoprazole. About 1050 adults who were healed in a prior trial will take either high or low dose lin…

    Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control

    Last updated May 17, 2026 06:46 UTC

  • New GERD drug aims to heal esophagus faster than current treatment

    Disease control Not yet recruiting

    This study tests a new medicine called linaprazan glurate to see if it heals esophagus damage from GERD better than the standard drug lansoprazole. About 500 adults with erosive esophagitis will take either the new drug or the standard one for up to 8 weeks. Doctors will use came…

    Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control

    Last updated May 15, 2026 11:56 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space